XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 13.04%342M | ---- | 11.68%302.55M | ---- | 5.33%270.92M | ---- | 19.14%257.2M | ---- | 8.97%215.88M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -681.82%-11.27M |
Investment loss (gain) | ---- | 64.73%-4.63M | ---- | -139.95%-13.12M | ---- | 4.05%-5.47M | ---- | ---5.7M | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 74.40%-991K |
Impairment and provisions: | ---- | 685.19%29.82M | ---- | -87.64%3.8M | ---- | -19.62%30.73M | ---- | 76.35%38.23M | ---- | 72.47%21.68M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -20.85%892K |
-Other impairments and provisions | ---- | 554.80%20.05M | ---- | -79.09%3.06M | ---- | -56.30%14.65M | ---- | 61.29%33.53M | ---- | 81.66%20.79M |
Revaluation surplus: | ---- | ---1.14M | ---- | ---- | ---- | -295.75%-10.45M | ---- | 29.66%5.34M | ---- | 124.44%4.12M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 124.44%4.12M |
Asset sale loss (gain): | ---- | -233,210.94%-15.03M | ---- | -106.61%-6.44K | ---- | -30.32%97.42K | ---- | 336.93%139.82K | ---- | -75.57%32K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -233,210.94%-15.03M | ---- | -106.61%-6.44K | ---- | -30.32%97.42K | ---- | 336.93%139.82K | ---- | -75.57%32K |
Depreciation and amortization: | ---- | 16.44%186M | ---- | 7.54%159.74M | ---- | 9.52%148.54M | ---- | -2.94%135.63M | ---- | 4.03%139.73M |
-Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.27%143.19M |
-Amortization of intangible assets | ---- | 1.15%4.5M | ---- | 1.61%4.44M | ---- | 6.84%4.37M | ---- | 3.61%4.09M | ---- | -12.16%3.95M |
-Other depreciation and amortization | ---- | -19.16%-8.12M | ---- | 2.71%-6.81M | ---- | 2.72%-7M | ---- | 2.87%-7.2M | ---- | 1.23%-7.41M |
Financial expense | ---- | 81.51%11.58M | ---- | 6.23%6.38M | ---- | 39.29%6.01M | ---- | -89.09%4.31M | ---- | 10.75%39.54M |
Operating profit before the change of operating capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 13.95%408.72M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 53.21%-8.24M | ---- | -189.25%-17.61M | ---- | 17.85%-6.09M | ---- | -780.30%-7.41M | ---- | 96.47%-842K |
Accounts receivable (increase)decrease | ---- | -1,273.75%-471.97M | ---- | 48.24%-34.36M | ---- | 15.10%-66.37M | ---- | -2.98%-78.18M | ---- | -0.22%-75.91M |
Accounts payable increase (decrease) | ---- | 278.98%573.34M | ---- | 164.98%151.28M | ---- | -55.87%57.09M | ---- | -12.48%129.38M | ---- | 245.62%147.83M |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -57.52%14.26M |
Cash from business operations | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 47.30%494.05M |
China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -81.58%-35.94M |
Special items of business | ---- | -818.81%-19.44M | ---- | 129.04%2.7M | ---- | -252.58%-9.31M | ---- | ---2.64M | ---- | ---- |
Adjustment items of business operations | 10.91%45.75M | 14.87%641.74M | 325.29%41.25M | 31.45%558.65M | 266.55%9.7M | -11.26%425.01M | -222.37%-5.82M | --478.94M | --4.76M | ---- |
Net cash from operations | 10.91%45.75M | 10.86%622.3M | 325.29%41.25M | 35.04%561.35M | 266.55%9.7M | -12.72%415.69M | -222.37%-5.82M | 3.97%476.3M | -96.59%4.76M | 45.15%458.11M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 681.82%11.27M |
Dividend received - investment | --99.72K | -74.01%5.1M | ---- | 105.79%19.64M | --12.41M | -65.86%9.54M | ---- | --27.96M | --22K | ---- |
Sale of fixed assets | --69.8K | 745.96%25.77M | ---- | 17.42%3.05M | ---- | 243.38%2.59M | -41.09%90.72K | 163.28%755.6K | --154K | 362.90%287K |
Purchase of fixed assets | 50.12%-215.12M | -64.68%-1.11B | -86.46%-431.26M | -108.21%-674.79M | -370.47%-231.29M | -12.98%-324.08M | -13.06%-49.16M | -58.12%-286.86M | 14.00%-43.48M | -55.44%-181.42M |
Recovery of cash from investments | ---- | ---- | ---- | 22.62%610.62M | 161.88%419M | -49.90%498M | --160M | -66.00%994M | ---- | -39.79%2.92B |
Cash on investment | ---- | 77.01%-115.2M | 75.54%-115.2M | -48.22%-501M | -175.44%-471M | 70.71%-338M | ---171M | 60.63%-1.15B | ---- | 39.49%-2.93B |
Other items in the investment business | 88.09%4.41M | 0.00%1M | 103.73%2.34M | -88.24%1M | 72.52%1.15M | 200.00%8.5M | 155.79%666.75K | ---8.5M | -136.26%-1.2M | ---- |
Net cash from investment operations | 61.31%-210.54M | -120.61%-1.19B | -101.73%-544.12M | -277.48%-541.48M | -354.06%-269.73M | 66.38%-143.44M | -33.49%-59.4M | -139.89%-426.64M | 91.18%-44.5M | -102.95%-177.85M |
Net cash before financing | 67.23%-164.79M | -2,979.13%-572.28M | -93.39%-502.87M | -92.70%19.88M | -298.65%-260.03M | 448.28%272.25M | -64.13%-65.23M | -82.28%49.65M | 89.10%-39.74M | 22.93%280.26M |
Cash flow from financing activities | ||||||||||
New borrowing | -34.51%261.94M | -8.57%500M | -10.49%400M | 36.72%546.86M | 48.95%446.86M | -34.15%400M | -49.77%300M | 51.87%607.47M | 49.32%597.29M | -46.67%400M |
Refund | 42.46%-115.22M | 44.26%-305.5M | 55.41%-200.26M | -14.08%-548.06M | -17.98%-449.08M | 40.54%-480.42M | 34.16%-380.64M | -41.11%-807.92M | -37.32%-578.15M | 1.01%-572.56M |
Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 14.19%-31.25M |
Dividends paid - financing | -22.66%-6.79M | -4.04%-146.66M | -20.39%-5.54M | 0.16%-140.97M | 3.36%-4.6M | -11.98%-141.2M | 57.96%-4.76M | -38.08%-126.09M | ---11.32M | -41.70%-91.32M |
Absorb investment income | ---- | -61.43%8.1M | ---- | --21M | ---- | ---- | ---- | ---- | ---- | --7.28M |
Other items of the financing business | -72.34%44.62M | -9.57%248.59M | -1.21%161.29M | 730.84%274.88M | --163.26M | 1,343.90%33.08M | ---- | ---2.66M | ---- | ---- |
Net cash from financing operations | -48.09%184.55M | 98.11%304.53M | 127.22%355.5M | 181.53%153.72M | 283.21%156.45M | 42.73%-188.53M | -1,191.75%-85.4M | -13.74%-329.2M | 120.05%7.82M | -160.98%-289.45M |
Effect of rate | --49.08K | -67.19%103.16K | ---- | 158.39%314.37K | ---- | -265.52%-538.44K | -78.00%38.72K | 98.22%-147.31K | 102.30%176K | ---8.29M |
Net Cash | 113.41%19.76M | -254.24%-267.75M | -42.28%-147.37M | 107.36%173.6M | 31.24%-103.57M | 129.95%83.72M | -371.89%-150.62M | -2,942.88%-279.55M | 92.09%-31.92M | -101.31%-9.19M |
Begining period cash | -36.34%490.26M | 29.78%757.89M | 31.87%770.09M | 16.61%583.98M | 15.68%583.98M | -35.84%500.8M | -35.65%504.8M | -2.19%780.5M | -1.69%784.5M | 736.99%797.97M |
Cash at the end | -18.09%510.07M | -35.32%490.24M | 29.62%622.72M | 29.78%757.89M | 35.62%480.4M | 16.61%583.98M | -52.94%354.21M | -35.84%500.8M | 94.69%752.75M | -2.19%780.5M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.